80 related articles for article (PubMed ID: 16612091)
1. Therapy with budesonide in patients with refractory sprue.
Daum S; Ipczynski R; Heine B; Schulzke JD; Zeitz M; Ullrich R
Digestion; 2006; 73(1):60-8. PubMed ID: 16612091
[TBL] [Abstract][Full Text] [Related]
2. High rates of complications and substantial mortality in both types of refractory sprue.
Daum S; Ipczynski R; Schumann M; Wahnschaffe U; Zeitz M; Ullrich R
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):66-70. PubMed ID: 19011576
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of budesonide therapy in the early phase of treatment of adult coeliac disease patients with malabsorption: an in vivo/in vitro pilot study.
Ciacci C; Maiuri L; Russo I; Tortora R; Bucci C; Cappello C; Santonicola A; Luciani A; Passananti V; Iovino P
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1170-6. PubMed ID: 19473192
[TBL] [Abstract][Full Text] [Related]
4. Features of Adult Autoimmune Enteropathy Compared With Refractory Celiac Disease.
Sharma A; Choung RS; Wang XJ; Russo PA; Wu TT; Nehra V; Murray JA
Clin Gastroenterol Hepatol; 2018 Jun; 16(6):877-883.e1. PubMed ID: 29307846
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution.
Mauriño E; Niveloni S; Cherñavsky AC; Sugai E; Vázquez H; Pedreira S; Periolo N; Mazure R; Smecuol E; Moreno ML; Litwin N; Nachman F; Kogan Z; Bai JC
Acta Gastroenterol Latinoam; 2006 Mar; 36(1):10-22. PubMed ID: 16706073
[TBL] [Abstract][Full Text] [Related]
6. A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis.
Kirwan JR; Hällgren R; Mielants H; Wollheim F; Bjorck E; Persson T; Book C; Bowman S; Byron M; Cox N; Field M; Kanerud L; Leirisalo-Repo M; Malaise M; Mohammad A; Palmer R; Petersson IF; Ringertz B; Sheldon P; Simonsson M; Snowden N; Van den Bosch F
Ann Rheum Dis; 2004 Jun; 63(6):688-95. PubMed ID: 15140776
[TBL] [Abstract][Full Text] [Related]
7. Budesonide in the treatment of refractory celiac disease.
Brar P; Lee S; Lewis S; Egbuna I; Bhagat G; Green PH
Am J Gastroenterol; 2007 Oct; 102(10):2265-9. PubMed ID: 17581265
[TBL] [Abstract][Full Text] [Related]
8. Azathioprine in refractory sprue: results from a prospective, open-label study.
Mauriño E; Niveloni S; Cherñavsky A; Pedreira S; Mazure R; Vazquez H; Reyes H; Fiorini A; Smecuol E; Cabanne A; Capucchio M; Kogan Z; Bai JC
Am J Gastroenterol; 2002 Oct; 97(10):2595-602. PubMed ID: 12385445
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of high intestinal output syndrome with budesonide in patients with Crohn's disease and ileostomy.
Ecker KW; Stallmach A; Löffler J; Greinwald R; Achenbach U
Dis Colon Rectum; 2005 Feb; 48(2):237-42. PubMed ID: 15714248
[TBL] [Abstract][Full Text] [Related]
10. Budesonide for the treatment of collagenous colitis: first results of a pilot trial.
Tromm A; Griga T; Möllmann HW; May B; Müller KM; Fisseler-Eckhoff A
Am J Gastroenterol; 1999 Jul; 94(7):1871-5. PubMed ID: 10406251
[TBL] [Abstract][Full Text] [Related]
11. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
Novacek G; Kleinberger M; Vogelsang H; Moser G; Lochs H
Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
[TBL] [Abstract][Full Text] [Related]
12. A comparison of budesonide with prednisolone for active Crohn's disease.
Rutgeerts P; Löfberg R; Malchow H; Lamers C; Olaison G; Jewell D; Danielsson A; Goebell H; Thomsen OO; Lorenz-Meyer H
N Engl J Med; 1994 Sep; 331(13):842-5. PubMed ID: 8078530
[TBL] [Abstract][Full Text] [Related]
13. Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
Tromm A; Bunganič I; Tomsová E; Tulassay Z; Lukáš M; Kykal J; Bátovský M; Fixa B; Gabalec L; Safadi R; Kramm HJ; Altorjay I; Löhr H; Koutroubakis I; Bar-Meir S; Stimac D; Schäffeler E; Glasmacher C; Dilger K; Mohrbacher R; Greinwald R;
Gastroenterology; 2011 Feb; 140(2):425-434.e1; quiz e13-4. PubMed ID: 21070781
[TBL] [Abstract][Full Text] [Related]
14. Open-Capsule Budesonide for Refractory Celiac Disease.
Mukewar SS; Sharma A; Rubio-Tapia A; Wu TT; Jabri B; Murray JA
Am J Gastroenterol; 2017 Jun; 112(6):959-967. PubMed ID: 28323276
[TBL] [Abstract][Full Text] [Related]
15. Etiology of nonresponsive celiac disease: results of a systematic approach.
Abdulkarim AS; Burgart LJ; See J; Murray JA
Am J Gastroenterol; 2002 Aug; 97(8):2016-21. PubMed ID: 12190170
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
[TBL] [Abstract][Full Text] [Related]
18. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
[TBL] [Abstract][Full Text] [Related]
19. [Collagenous sprue].
Hafkemeyer P; Herbst E; Köhler G; Fuhrmann K; Kreisel W
Dtsch Med Wochenschr; 1995 Oct; 120(42):1430-4. PubMed ID: 7555672
[TBL] [Abstract][Full Text] [Related]
20. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis.
Kirwan JR; Hickey SH; Hällgren R; Mielants H; Björck E; Persson T; Wollheim FA
Arthritis Rheum; 2006 May; 54(5):1415-21. PubMed ID: 16645969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
